# DOXEPIN HYDROCHLORIDE
> **ANDA212997** · Abbreviated New Drug Application (Generic) · Sponsor: LANNETT CO INC · Approved 2020-07-24
## Drug
- **FDA Application Number:** ANDA212997
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DOXEPIN HYDROCHLORIDE
- **Generic name:** Doxepin Hydrochloride
- **Active ingredients:** DOXEPIN HYDROCHLORIDE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** LANNETT CO INC
- **First approval:** 2020-07-24
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212997)
---
*MORVS · CC0 1.0*